Forian Inc

Forian, Inc. engages in the provision of healthcare information, analytics and technology services. The firm provides a suite of SaaS solution, as well as cannabis dispensaries. The company was founded by Max C. Wygod and Adam Dublin on October 15, 2020 and is headquartered in Newtown, PA.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Forian Inc reports strong revenue growth post-divestiture, eyes profitability

Forian Inc showcased strong revenue growth in Q4 2022 and full year 2022, driven by the divestiture of cannabis software assets and focus on healthcare information.
While facing net losses, the company exceeded revenue guidance and has a solid contracted backlog for 2023, aiming for positive adjusted EBITDA in the latter part of the year.
Challenges include ongoing profitability concerns and the need for operational efficiency improvements, but opportunities lie in expanding the healthcare information business and capturing market share.
Overall, Forian's strategic shifts have positioned the company for growth and profitability, with a clear focus on healthcare technology and a strong revenue outlook for 2023.

Forian Inc reports strong Q1 earnings and eyes future growth

Forian Inc delivered robust financial performance in Q1 2023, with significant revenue growth and improved net income.
While challenges persist, the company's focus on healthcare analytics and strong balance sheet sets a solid foundation for future growth.
Opportunities lie ahead for Forian to leverage its expertise and financial stability for sustained expansion and strategic initiatives.

Forian Inc excels in Q2 2023, eyes expansion and acquisitions

Forian Inc's Q2 2023 performance reflects robust revenue growth and improved financial metrics, positioning the company for future success.
While challenges like net losses persist, strategic initiatives to enhance operational efficiency and profitability are underway.
Opportunities for expansion and acquisitions, coupled with a strong balance sheet, underscore Forian's potential for sustained growth and market leadership.

Forian Inc reports robust Q3 performance and eyes growth opportunities

Forian Inc delivered a strong third-quarter performance with revenue growth and improved profitability. The company's strategic wins and focus on data science-based offerings position it well for future growth.
While challenges such as market risks and customer acquisition impact exist, Forian's financial strength and opportunities for revenue growth and market expansion provide a positive outlook.
With a solid financial position, plans to capitalize on growth opportunities, and a commitment to innovation, Forian is poised to navigate challenges and leverage opportunities in the health care information sector.

Forian Inc reports solid Q4 earnings and projects growth in 2024

Forian Inc ended 2023 on a positive note, showcasing strong financial performance and strategic advancements. The company is poised for continued growth in 2024 despite market challenges, leveraging its data-driven ecosystem and product innovations.

Forian Inc reports stable Q1 performance and launches innovative products

Forian Inc's Q1 2024 performance showed stability in revenues, improved EBITDA, and strategic growth initiatives.
The company faces challenges in revenue growth and profitability but has opportunities in market expansion and product innovation.
By focusing on operational efficiency, new client acquisition, and corporate development, Forian Inc aims for sustained growth and profitability.

Forian Inc reports steady Q2 performance amidst market disruptions

Forian Inc's Q2 2024 performance was steady with flat revenue and a net loss, facing challenges from funding issues and data disruptions.
Despite these challenges, the company remains confident, plans to invest in assets, and sees opportunities for growth.
Market disruptions led to revised revenue outlook, but Forian's financial stability and strategic focus position it for future success.

Forian Inc. reports steady Q3 performance and acquires Kyber Data Science

Forian Inc. demonstrates resilience with steady financial performance and strategic acquisitions to bolster its market position and data analytics capabilities.
Challenges from past customer losses and data disruptions are being addressed through ongoing efforts, while opportunities for growth and innovation are actively pursued.
Investors should note Forian's commitment to enhancing shareholder value through strategic initiatives and its confidence in maintaining competitiveness in the market.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NEWTOWN, PA, April 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire - Forian Inc. (Nasdaq:FORA), a provider of software, data, and analytics-enabled services for the healthcare and cannabis industries, will announce its financial results for the three months ended March 31, 2022 on Thursday, May 12, 2022 after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on May 12, 2022 to discuss the results.

Forian Inc. to Announce 2022 First Quarter Results on May 12, 2022

Newtown, PA, April 05, 2022 (GLOBE NEWSWIRE) -- via  NewMediaWire -- Forian Inc. (Nasdaq: FORA), a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, announced that its subsidiary, Bio-Tech Medical Software, Inc. (d/b/a BioTrack), successfully completed the planned April 1, 2022 launch of its New Mexico state traceability system for adult use cannabis sales.  This latest state partnership demonstrates the continued expansion of Forian's BioTrack™ state traceability system.

Forian BioTrack Launches New Mexico Traceability Software for Adult Use Cannabis

Forian Inc's (FORA) CEO Dan Barton on Q4 2021 Results - Earnings Call Transcript

FY21 revenue of $16.9 million met high end of revenue outlook Company provides outlook for continued growth in FY22

Forian Inc. Announces Fourth Quarter and Full Year 2021 Financial Results

NEWTOWN, PA, March 09, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Forian Inc. (Nasdaq:FORA), a leading provider of technology, predictive analytics and data science driven software solutions for the healthcare and cannabis industries, has been invited to attend the 34th Annual Roth Conference to be held March 13-15, 2022, at The Ritz Carlton, Laguna Niguel located in Dana Point, California.

Forian Inc. to Present at 34th Annual Roth Conference

NEWTOWN, Pa., March 07, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Forian Inc. (Nasdaq:FORA), a provider of software, data, and analytics-enabled services for the healthcare and cannabis industries, will announce its financial results for the fourth quarter and year ending on December 31, 2021 on Thursday, March 24, 2022 after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on March 24, 2022 to discuss the results.

Forian Inc. to Announce Fourth Quarter and Full Year 2021 Results on March 24, 2022

NEWTOWN, PA, Feb. 28, 2022 (GLOBE NEWSWIRE) -- via  NewMediaWire -- Forian Inc. (NASDAQ: FORA), a leading provider of technology, predictive analytics and data science driven software solutions for the healthcare and cannabis industries, announced that the State of Florida Department of Health Negotiators have unanimously voted to choose BioTrack as the track and trace system for the Florida Department of Health's Office of Medical Marijuana Use. This vote was affirmed by the Department of Health's Notice of Intent to Award, which can be found HERE.

Florida Chooses BioTrack as the State's Cannabis Track and Trace System

Forian Inc. (FORA) CEO Daniel Barton on Q3 2021 Results - Earnings Call Transcript

TORONTO--(BUSINESS WIRE)---- $FORA #VerticalScope--VerticalScope announces three additional acquisitions.

VerticalScope Announces Three Additional Acquisitions

TORONTO--(BUSINESS WIRE)---- $FORA #VerticalScope--VerticalScope Announces Third Quarter 2021 Financial Results

VerticalScope Announces Third Quarter 2021 Financial Results

NEWTOWN, Pa., Oct. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Forian Inc. (Nasdaq:FORA), a provider of software, data, and analytics-enabled services for the healthcare and cannabis industries, will announce its financial results for the three months ended September 30, 2021 on Thursday, November 11, 2021 after the close of the market. The Company will host a conference call at 4:30 p.m. (ET) on November 11, 2021 to discuss the results. To access the conference call, from the US dial (855) 940-5323 or for International calls dial (929) 517-0423, and enter Conference ID 2915339. This information is also available on our website at www.forian.com/investors. The earnings release along with a replay of the call promptly following its conclusion will be available at the same site.

Forian Inc. to Announce 2021 Third Quarter Results on November 11, 2021

Forian Inc. (NASDAQ:FORA) announced on Wednesday a $24 million valued private placement of 3.5% convertible notes. The company, which provides analytics services and software solutions to healthcare and cannabis industries, also revealed it has appointed Michael Vesey as the new Chief Financial Officer.

Forian To Raise $24M Via Private Placement Of 3.5% Convertible Notes, Appoints New CFO

Wayside Technology Group

NEWTOWN, Pa., Sept. 1, 2021 /PRNewswire/ -- Forian Inc. (NASDAQ: FORA), a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, today announced the following: Convertible Notes Offering The Company has entered into a convertible note purchase agreement (the "Note Purchase Agreement") with a select group of institutional and accredited investors pursuant to which the Company will issue  $24,000,000 aggregate principal amount at 100% of par value of its 3.5% convertible notes due 2025 (the "Notes").

Forian Inc. Announces $24 Million Private Placement of 3.5% Convertible Notes due 2025, Appoints New Chief Financial Officer

Mind Medicine MindMed

Psychedelics-focused medicines company Mind Medicine Inc. (NASDAQ:MNMD), (NEO: MMED) announced Tuesday that it has teamed up with Forian Inc. (NASDAQ:FORA), a provider of evidence-based support for more comprehensive clinical and commercial decision-making. MindMed and Forian will collaborate to develop best practices for using real-world evidence ("RWE") information to help improve the health and lives of psychiatric patients.

MindMed Teams Up With Forian To Improve Real-World Evidence Data To Help Psychiatric Patients

NEW YORK, Aug. 24, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired therapies, has agreed to work with Forian Inc. (NASDAQ: FORA), a leading provider of evidence-based support for more comprehensive clinical and commercial decision-making. MindMed and Forian will collaborate to develop best practices for using real-world evidence ("RWE") information to help improve the health and lives of psychiatric patients.

MindMed Announces Collaboration With Forian To Advance Development Of Personalized Psychiatry For Anxiety Disorders

Forian Inc. (FORA) CEO Daniel Barton on Q2 2021 Results - Earnings Call Transcript

NEWTOWN, Pa., Aug. 12, 2021 /PRNewswire/ -- Forian Inc. (NASDAQ: FORA), a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, today announced results for the fiscal quarter ended June 30, 2021.

Forian Inc. Announces Second Quarter Fiscal 2021 Financial Results

NEWTOWN, Pa., July 22, 2021 /PRNewswire/ -- Forian Inc. (Nasdaq:FORA), a provider of software and technology-enabled services for the healthcare and cannabis industries, will announce its financial results for the three months ended June 30, 2021 on Thursday, August 12, 2021 after the close of the market.

Forian Inc. to Announce 2021 Second Quarter Results on August 12, 2021

Unique suite of SaaS data management capabilities and proprietary analytics Expects to have $10 million on hand post-merger Educating healthcare clients on data connected to medical cannabis What Forian does: Forian Inc (NASDAQ:FORA) came into being when Helix Technologies Inc, an operating services platform provider to the legal cannabis industry, merged with Medical Outcomes Research Analytics LLC (MOR), a healthcare data provider. Forian began trading on the Nasdaq capital market under the symbol FORA on March 3.

Forian emerges from Helix Technologies/MOR Analytics combination to deliver data-driven improvements to the healthcare and cannabis markets

Forian Inc (NASDAQ:FORA) will join the broad-market Russell 3000 Index on June 28, according to a preliminary list of additions announced last week.  The move will take effect after the index's annual reconstitution, which captures the 4,000 largest US stocks as of May 7 and ranks them by total market capitalization.

Forian earns a place on the Russell 3000 Index

NEWTOWN, Pa., June 7, 2021 /PRNewswire/ -- Forian Inc. is set to join the broad-market Russell 3000 ® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28, 2021, according to a preliminary list of additions posted June 4, 2021.

Forian Inc. Set to Join Russell 3000® Index

Forian Inc (NASDAQ:FORA) has reported its first quarter results, posting revenue of roughly $1.6 million in its first filing since its combination with Helix Technologies Inc and March 3 Nasdaq listing.  For the three months ended March 31, which includes 29 days with Helix under its umbrella, Forian saw revenue jump year-over-year to $1.6 million from $66,667 in the same quarter in 2020.

Forian reports major revenue bump in first quarterly results since Helix Technologies combination

Forian, Inc. (FORA) CEO Daniel Barton on Q1 2021 Results - Earnings Call Transcript

NEWTOWN, Pa., May 17, 2021 /PRNewswire/ -- Forian Inc. (NASDAQ: FORA), a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, today announced results for its fiscal first quarter ended March 31, 2021.

Forian Inc. Announces First Quarter Fiscal 2021 Financial Results

NEWTOWN, Pa., May 4, 2021 /PRNewswire/ -- Forian Inc. (Nasdaq:FORA), a provider of software and technology-enabled services for the healthcare and cannabis industries, will announce its financial results for the three months ended March 31, 2021 before the market opens on Monday, May 17, 2021.

News for Forian Inc Stock (FORA)